Hyaluronic acid derived maytansine prodrug, preparation method thereof and application of maytansine prodrug in preparation of tumor target treatment medicines
A technology of hyaluronic acid and maytansine, applied in anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve problems such as damage and interstitial lung disease, toxic and side effects, tissue damage, etc., and achieve preservation of anti-tumor activity, Good biological activity and the effect of maintaining medicinal properties
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0037] Example 1 Synthesis of hyaluronic acid-derivatized maytansine prodrug (HA-SS-DM1) ( M nHA =35 kDa, DM1% =20 wt.%)
[0038] First, aminodithiopyridine hydrochloride (PDA·HCl) (34.7 mg, 0.156 mmol) was added to an aqueous solution of hyaluronic acid (HA) (400 mg, 1.04 mmol carboxyl) (20 mL) at room temperature and the entire solution The pH was adjusted to 6.5, and 4-(4,6-dimethoxytriazin-2-yl)-4-methylmorpholine hydrochloride (DMTMM) (57.51 mg, 0.208 mmol) was added thereto at 35 After stirring at °C for 24 hours, dialysis and lyophilization were performed to obtain hyaluronic acid-dithiopyridine (HA-SS-Py). The product yield was 85%. NMR results showed that its structure was hyaluronic acid-dithiopyridine (HA-SS-Py), in which the degree of substitution (DS) of the dithiopyridine functional group (-SS-Py) was 6%. see NMR image 3 , 1 H NMR (D 2 O): Hyaluronic acid (HA): δ (ppm) 1.86-2.01, 3.28-4.02, and 4.21-4.75; Dithiopyridine functional group (-SS-Py): δ (ppm)...
Example Embodiment
[0040] Example 2 Synthesis of hyaluronic acid-derivatized maytansine prodrug (HA-SS-DM1) ( M nHA = 35 kDa, DM1% = 26 wt.%)
[0041] First, aminodithiopyridine hydrochloride (PDA·HCl) (53 mg, 0.24 mmol) was added to an aqueous solution of hyaluronic acid (HA) (400 mg, 1.04 mmol carboxyl) (20 mL) at room temperature and the entire solution was added The pH was adjusted to 6.5, and 4-(4,6-dimethoxytriazin-2-yl)-4-methylmorpholine hydrochloride (DMTMM) (86.3 mg, 0.316 mmol) was added thereto at 35 After stirring at °C for 24 hours, dialysis and lyophilization were performed to obtain hyaluronic acid-dithiopyridine (HA-SS-Py). The product yield was 85%. NMR results showed that its structure was hyaluronic acid-dithiopyridine (HA-SS-Py), in which the degree of substitution (DS) of the dithiopyridine functional group (-SS-Py) was 8.5%.
[0042] Under nitrogen protection, HA-SS-Py (100 mg, 40.6 μmol dithiopyridine functional group) dissolved in 8 mL of secondary water was added t...
Example Embodiment
[0043] Example 3 Synthesis of hyaluronic acid derivatized maytansine prodrug (HA-SS-DM1) ( M nHA =35 kDa, DM1% =30 wt.%)
[0044] First, under nitrogen protection, in an aqueous solution of hyaluronic acid (HA) (400 mg, 1.04 mmol carboxyl) (20 mL) was added aminodithiopyridine hydrochloride (PDA•HCl) (70 mg, 0.312 mmol) and the entire The pH of the solution was adjusted to 6.5, and then 4-(4,6-dimethoxytriazin-2-yl)-4-methylmorpholine hydrochloride (DTMMM) (115.01 mg, 0.416 mmol) was added thereto, After stirring the reaction at 35°C for 24 hours, dialysis and lyophilization were performed to obtain hyaluronic acid-dithiopyridine (HA-SS-Py). The product yield was 85%. NMR results showed that its structure was hyaluronic acid-dithiopyridine (HA-SS-Py), in which the degree of substitution (DS) of the dithiopyridine functional group (-SS-Py) was 11%.
[0045] Under nitrogen protection, add HA-SS-Py (100 mg, 54.2 micromoles of dithiopyridine functional group) dissolved in 8 m...
PUM
Property | Measurement | Unit |
---|---|---|
The average particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
The average particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap